Growing vascular endothelial cells express somatostatin subtype 2 receptors

British Journal of Cancer

Volumn 85, Issue 2, 2001, Pages 266-272

  Watson, J C ^a   Balster, D A ^d   Gebhardt, B M ^a,c   O'Dorisio, T M ^d   O'Dorisio, M S ^d   Espenan, G D ^b   Drouant, G J ^a   Woltering, E A ^a,c,e  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Gene expression; Receptor subtypes; Somatostatin; Somatostatin receptors; Vascular endothelium

Indexed keywords

CYTOTOXIC AGENT; RADIOISOTOPE; RNA; SOMATOSTATIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCINTIANGIOGRAPHY; VASCULAR ENDOTHELIUM;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CULTURE TECHNIQUES; DNA PRIMERS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0034934877     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1881     Document Type: Article

References (33)

1. Somatostatin receptor gene expression in neuroblastoma
2. Segmental expression of somatostatin receptor subtypes sst 1 and sst 2 in tubules an glomeruli of human kidney
3. Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent
4. Identification of human leukocytes bearing receptors for somatostatin and glucagon
5. Somatostatin receptor-positive primary breast tumors: Genetic, patient and tumor characteristics
6. Novel in vitro assay for human angiogenesis
7. Inhibition of corneal angiogenesis by octreotide acetate (OA) in a rabbit micropocket model
8. 125l-lanreotide in women with primary breast cancer
9. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995)
10. Expression of somatostatin receptors in peritumoral veins of human tumors
11. Experiences with high-dose radiopeptide therapy: The health physics perspective
12. 111ln-DTPA-D-Phel]-octreotide scintigraphy in patients with hormone-refractory prostatic adenocarcinoma can predict therapy outcome with octreotide treatment: A pilot study
13. Intraoperative detection and resection of occult neuroblastoma: A technique exploiting somatostatin receptor expression
14. 111ln-pentetreotide: Initial observations and future directions
15. Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity
16. 111ln]-labeled DTPA-D-[Phe1]-octreotide scintigraphy
17. Identification of somatostatin receptors on human neuroblastoma tumors
18. Post-receptor signal transduction mechanisms involved in octreotide-induced inhibition of angiogenesis
19. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238
20. High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interactions?
21. Somatostatin receptors and their subtypes in human tumors and peritumoral vessels
22. 125l-TYR(3)-octreotide and a hand-held gamma-detecting probe
23. Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma
24. Somatostatin receptor imaging: The presence of somatostatin receptors in rheumatoid arthritis
25. Initiation of kdr gene transcription is associated with the conversion of human vascular endothelium to an angiogenic phenotype
26. Somatostatin-like peptides alter calcium but not secretin sensitivity of gastrinoma cells
27. Somatostatin analogs inhibit angiogenesis in the chick chorioallantoic membrane
28. Detection of occult gastrinomas with iodine 125-labeled lanreotide and intraoperative gamma detection
29. The role of somatostatin analogs in the management of cancer patients
30. Somatostatin analogs: Angiogenesis inhibitors with novel mechanisms of action
31. Synthesis and characterization of multiply-tyrosinated, multiply-iodinated somatostatin analogs
32. The use of long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors
33. Preparation of 188Re-RC-160 somatostatin analog: A peptide for local/regional radiotherapy